A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours

British Journal of Cancer

Volumn 91, Issue 6, 2004, Pages 1119-1130

  Krona, C ^a   Ejeskar K ^a,b   Caren H ^a   Abel, F ^a   Sjoberg R M ^a   Martinsson, T ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

1p36; APITD1; Neuroblastoma; TFIID; TP53

Indexed keywords

MESSENGER RNA; PROTEIN P53; TRANSCRIPTION FACTOR IID;

AP1TD1 GENE; APOPTOSIS; ARTICLE; CELL GROWTH; CHILDHOOD CANCER; CHROMOSOME 1P; CONTROLLED STUDY; DNA SEQUENCE; GENE INACTIVATION; GENE LOCATION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; DNA PRIMERS; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 5044238691     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602083     Document Type: Article

References (38)

1. Abel F, Sjöberg R-M, Ejeskär K, Krona C, Martinsson T (2002) Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours. Br J Cancer 86: 596-604
2. Bauer A, Savelyeva L, Claas A, Praml C, Berthold F, Schwab M (2001) Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosomes Cancer 31: 228-239
3. Benn DE, Dwight T, Richardson AL, Delbridge L, Bambach CP, Stowasser M, Gordon RD, Marsh DJ, Robinson BG (2000) Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p. Cancer Res 60: 7048-7051
4. Bridge JA, Liu J, Weibolt V, Baker KS, Perry D, Kruger R, Qualman S, Barr F, Sorensen P, Triche T, Suijkerbuijk R (2000) Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study. Genes Chromosomes Cancer 27: 337-344
5. Brodeur GM, Green AA, Hayes FA, Williams KJ, Williams DL, Tsiatis AA (1981) Cytogenetic features of human neuroblastomas and cell lines. Cancer Res 41: 4678-4686
6. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, De Bernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Roald B, Sawada T, Seeger RC, Tsuchida Y, Voute PA (1993) Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 11: 1466-1477
7. Brodeur GM, Seeger RC, Barrett A, Berthold F, Castleberry RP, D'Angio G, De Bernardi B, Evans AE, Favrot M, Freeman AI, Haase G, Hartmann O, Hayes FA, Helson L, Kemshead J, Lampert F, Ninane J, Ohkawa H, Philip T, Pinkerton CR, Pritchard J, Sawada T, Siegel S, Smith EI, Tsuchida Y, Voute PA (1988) International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol 6: 1874-1881
8. Brodeur GM, Sekhon G, Goldstein MN (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40: 2256-2263
9. Bussey KJ, Lawce HJ, Olson SB, Arthur DC, Kalousek DK, Krailo M, Giller R, Heifetz S, Womer R, Magenis RE (1999) Chromosome abnormalities of eighty-one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences - a Children's Cancer Group study. Genes Chromosomes Cancer 25: 134-146
10. Caron H, Peter M, van Sluis P, Speleman F, de Kraker J, Laureys G, Michon J, Brugieres L, Voute PA, Westerveld A, Slater R, Delattre O, Versteeg R (1995) Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification. Hum Mol Genet 4: 535-539
11. Caron H, Spieker N, Godfried M, Veenstra M, van Sluis P, de Kraker J, Voute P, Versteeg R (2001) Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30: 168-174
12. Ejeskär K, Abel F, Sjöberg R-M, Bäckström J, Kogner P, Martinsson T (2000) Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.2-3, but absence of mutations in primary tumors. Cytogenet Cell Genet 89: 62-66
13. Ejeskär K, Sjöberg R-M, Abel F, Kogner P, Ambros PF, Martinsson T (2001) Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours. Med Pediatr Oncol 36: 61-66
14. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC (1994) Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54: 2331-2333
15. Hosoi G, Hara J, Okamura T, Osugi Y, Ishihara S, Fukuzawa M, Okada A, Okada S, Tawa A (1994) Low frequency of the p53 gene mutations in neuroblastoma. Cancer 73: 3087-3093
16. Ichimiya S, Nimura Y, Kageyama H, Takada N, Sunahara M, Shishikura T, Nakamura Y, Sakiyama S, Seki N, Ohira M, Kaneko Y, McKeon F, Caput D, Nakagawara A (1999) p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene 18: 1061-1066
17. Imamura J, Bartram CR, Berthold F, Harms D, Nakamura H, Koeffler HP (1993) Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification. Cancer Res 53: 4053-4058
18. Komuro H, Hayashi Y, Kawamura M, Hayashi K, Kaneko Y, Kamoshita S, Kanada R, Yamamoto K, Kongo T, Yamada M, Tsuchida Y (1993) Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res 53: 5284-5288
19. Kozak M (1996) Interpreting cDNA sequences: some insights from studies on translation. Mamm Genome 7: 563-574
20. Krona C, Ejeskär K, Abel F, Kogner P, Bjelke J, Björk E, Sjöberg R-M, Martinsson T (2003) Screening for gene mutations in a 500kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 22: 2343-2351
21. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351: 453-456
22. Li LC, Dahiya R (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18: 1427-1431
23. Lu H, Levine AJ (1995) Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc Natl Acad Sci USA 92: 5154-5158
24. Maris JM, Guo C, Blake D, White PS, Hogarty MD, Thompson PM, Rajalingam V, Gerbing R, Stram DO, Matthay KK, Seeger RC, Brodeur GM (2001) Comprehensive analysis of chromosome 1p deletions in neuroblastoma. Med Pediatr Oncol 36: 32-36
25. Maris JM, White PS, Beltinger CP, Sulman EP, Castleberry RP, Shuster JJ, Look AT, Brodeur GM (1995) Significance of chromosome 1p loss of heterozygosity in neuroblastoma. Cancer Res 55: 4664-4669
26. Martinsson T, Sjöberg R-M, Hallstensson K, Nordling M, Hedborg F, Rogner P (1997) Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours. Eur J Cancer 33: 1997-2001
27. Martinsson T, Sjöberg R-M, Hedborg F, Rogner P (1995) Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55: 5681-5686
28. Mostert M, Rosenberg C, Stoop H, Schuyer M, Timmer A, Oosterhuis W, Looijenga L (2000) Comparative genomic and in situ hybridization of germ cell tumors of the infantile testis. Lab Invest 80: 1055-1064
29. Nigro JM, Baker SJ, Preisinger AC, Jessup JM, Hosteller R, Cleary K, Bigner SH, Davidson N, Baylin S, Devilee P, Glover T, Collins FS, Weslon A, Modali R, Harris CC, Vogelslein B (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708
30. Ohira M, Kageyama H, Mihara M, Furula S, Machida T, Shishikura T, Takayasu H, Islam A, Nakamura Y, Takahashi M, Tomioka N, Sakiyama S, Kaneko Y, Toyoda A, Hallori M, Sakaki Y, Ohki M, Horii A, Soeda E, Inazawa J, Seki N, Kuma H, Nozawa I, Nakagawara A (2000) Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line. Oncogene 19: 4302-4307
31. Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ, Chaganti RS (1992) Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 52: 2285-2291
32. Schneider DT, Schuster AE, Fritsch MK, Calaminus G, Harms D, Gobel U, Perlman EJ (2001) Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Klin Peadiatr 213: 204-211
33. Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R (2001) Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1. Genes Chromosomes Cancer 31: 172-181
34. Steinberg R, Freud E, Zer M, Ziperman I, Goshen Y, Ash S, Slein J, Zaizov R, Avigad S (2000) High frequency of loss of heterozygosity for 1p35-p36 (D1S247) in Wilms tumor. Cancer Genet Cytogenet 117: 136-139
35. Stock C, Ambros IM, Strehl S, Zoubek A, Fink FM, Gadner H, Ambros PF (1995) Cytogenetic aspects of pediatric germ cell tumors. Klin Peadiatr 207: 235-241
36. Vogan K, Bernstein M, Leclerc JM, Brisson L, Brossard J, Brodeur GM, Pelletier J, Gros P (1993) Absence of p53 gene mutations in primary neuroblastomas. Cancer Res 53: 5269-5273
37. While PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, Valentine MB, Look AT, Enomoto H, Sakiyama S, Brodeur GM (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92: 5520-5524
38. While PS, Thompson PM, Seifried BA, Sulman EP, Jensen SJ, Guo C, Maris JM, Hogarty MD, Allen C, Biegel JA, Malise TC, Gregory SG, Reynolds CP, Brodeur GM (2001) Detailed molecular analysis of 1p36 in neuroblastoma. Med Pediatr Oncol 36: 37-41